EUVIMEDEUVIMED entdecken
Crossref

Measuring Change over Time on Cognitive Screening Measures: An Evaluation of the Psychometric Properties of ACE-III, CBI-R, and EMQ for the Purpose of Dementia Screening

Donnchadh F Murphy, Jonathan P Scott, Rupert F Noad

Dementia and Geriatric Cognitive Disorders · 2024

DOI: 10.1159/000534313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dementia and Geriatric Cognitive Disorders, 2024. Verfasst von Donnchadh F Murphy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health, University of Plymouth, Plymouth, UK. Hauptthemen laut MEDLINE: Psychometrics, Dementia, Neuropsychological Tests, Alzheimer Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cognitive screening measures are an established part of a dementia assessment and often include measures of subjective difficulties, e.g., Everyday Memory Questionnaire (EMQ), informant-rated difficulty, Cambridge Behavioural Inventory – Revised (CBI-R), and objective cognitive assessments like Addenbrooke’s Cognitive Examination (ACE-III). While these measures have validity for the purpose of diagnosing dementia, in clinical practice they are often used outside of their evidence base for the purpose of cognitive re-assessment. The current study sought to evaluate the psychometric properties for the repeated use of these assessments.

Methods

This study used a longitudinal design, which included 49 healthy controls, 33 people with subjective memory difficulties, and 10 people with Alzheimer’s disease (AD) being assessed twice, with approximately a 1-year interval between assessments.

Results

The EMQ has adequate re-test reliability (r = 0.78), but people with an AD diagnosis rated their memory as better than those with SMD, making it unsuitable as a measure. The CBI-R had moderate re-test reliability (r = 0.62). However, deterioration on the CBI-R was not useful for diagnosing AD. The ACE-III has high re-test reliability (r = 0.89). A change of five was associated with reasonable classification accuracy for identifying AD and achieved statistical significance.

Conclusion

Using a 1-year interval, of the three measures used in this study, only the ACE-III total score may be a useful measure of change over time, although it should be applied cautiously due to the lack of representativeness of the sample, and change scores should always be triangulated with other forms of evidence of deterioration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsychometricsDementiaNeuropsychological TestsAlzheimer DiseaseHumansMaleFemaleAgedReproducibility of ResultsLongitudinal StudiesAged, 80 and overSurveys and QuestionnairesMiddle AgedMemory DisordersMental Status and Dementia Tests

Stichwörter der Autor:innen

ACE-IIIAlzheimer’s dementiaCBI-RCognitive assessmentPsychometrics

Autor:innen und Institutionen

  • Faculty of Health, University of Plymouth, Plymouth, UK.
  • Clinical Neuropsychology, Livewell Southwest, Plymouth, UK.
  • Clinical Neuropsychology, Torbay and South Devon NHS Foundation Trust, Torquay, UK.
  • Clinical Neuropsychology, University Hospitals Plymouth, Plymouth, UK.

Zitieren

APA

Murphy, D. F., Scott, J. P., & Noad, R. F. (2024). Measuring Change over Time on Cognitive Screening Measures: An Evaluation of the Psychometric Properties of ACE-III, CBI-R, and EMQ for the Purpose of Dementia Screening. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000534313

Vancouver

Murphy DF, Scott JP, Noad RF. Measuring Change over Time on Cognitive Screening Measures: An Evaluation of the Psychometric Properties of ACE-III, CBI-R, and EMQ for the Purpose of Dementia Screening. Dementia and Geriatric Cognitive Disorders. 2024. doi:10.1159/000534313

BibTeX
@article{Murphy2024,
  author = {Murphy, Donnchadh F and Scott, Jonathan P and Noad, Rupert F},
  title = {Measuring Change over Time on Cognitive Screening Measures: An Evaluation of the Psychometric Properties of ACE-III, CBI-R, and EMQ for the Purpose of Dementia Screening},
  journal = {Dementia and Geriatric Cognitive Disorders},
  year = {2024},
  doi = {10.1159/000534313}
}
Kostenlos starten →